Diplomat Pharmacy (DPLO) Tops Q1 EPS by 5c

Diplomat Pharmacy (NYSE: DPLO) reported Q1 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $995.9 million versus the consensus estimate of $982.87 million.

For earnings history and earnings-related data on Diplomat Pharmacy (DPLO) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
• NewtekOne cuts EPS guidance, shifts focus to net interest income